- 2020
- Press releases - 16.07.2020
Type 1 Interferon Deficiency: A Blood based Signature for Detecting Patients at Risk of Severe Covid-19
In a study published in Science on July 13, teams from AP-HP, Inserm, Université of Paris, Institut Pasteur and Institut Imagine describe a unique and unexpected immunological phenotype in severe and critical patients, consisting of a severely impaired response of interferon (IFN) type I, associated with a persistent blood viral load and an excessive inflammatory response.
- Press releases - 10.07.2020
Having surgery under hypnosis, really?
Hypnosis fascinates by its esoteric, almost magical side. One thinks of the hypnotist who puts crowds to sleep… But there’s a whole other field in which hypnosis is being emulated, that of health. Listen only to our voice… Detox Channel cuts off false information.
- Press releases - 08.07.2020
Star-Shaped Brain Cells Shed Light on the Link Between Cannabis Use and Sociability
Cannabis use can lead to behavioral changes, including reduced social interactions in some individuals. To better understand the phenomenon, Inserm researcher Giovanni Marsicano and his team from NeuroCenter Magendie (Inserm/Université de Bordeaux), in collaboration with Juan Bolaños’ team from the University of Salamanca, have identified for the first time in mice the cerebral mechanisms underlying the relationship between cannabis and reduced sociability.
- Press releases - 08.07.2020
Growing-Up Milk: A Good Strategy to Prevent Iron Deficiency in Young Children
In France, the strategy for preventing iron deficiency in young children is partly based on the recommendation to use iron-fortified infant formula – including growing-up milk – when breastfeeding is discontinued. The researchers found that the consumption of iron-fortified infant formula very significantly reduced the risk of iron deficiency and met the recommended daily nutrition requirements for nearly half of the children.
- Press releases - 07.07.2020
Publication of a multicentre observational study, in the journal JAMA Neurology, to identify risk factors for the severity of COVID-19 in patients with multiple sclerosis in France
A study, aimed at identifying the risk factors for the severity of COVID-19 in patients with multiple sclerosis in France, was carried out by teams from the neurology department of the Pitié-Salpêtrière hospital AP -HP, from the Brain Institute (Inserm / CNRS / Sorbonne University) at the Pitié-Salpêtrière hospital AP-HP, from Sorbonne University and the neurology service of the Strasbourg CHU.
- Press releases - 04.07.2020
Discovery: Stopping inclusions in two treatment groups
Les deux bras testant la combinaison lopinavir/ritonavir avec ou sans interféron bêta sont arrêtés dans les essais cliniques Solidarity et Discovery. Compte tenu de la nature adaptative des deux essais, une réflexion est en cours sur l’évolution du protocole. Des publications dans des journaux internationaux à comité de lecture sont en préparation concernant tant l’évaluation de l’hydroxychloroquine que du lopinavir/ritonavir.
- Press releases - 02.07.2020
Artemisia miracle plant, really?
Depuis plusieurs années, un débat portant sur l’efficacité contre le paludisme de divers produits non pharmaceutiques à base d’Artemisia agite la communauté scientifique. Il fait son retour avec l’épidémie de Covid-19.
- Press releases - 23.06.2020
Menstrual Toxic Shock Syndrome: Encourage Proper Tampon Use to Limit Risks
In a study published in March 2020 in the journal EClinical Medicine, Prof. Gérard Lina’s team suggests simple measures to put in place for better tampon use during menstruation.
- Press releases - 17.06.2020
Alzheimer’s Disease: Sweet Snacks May Not Go Down So Well in Those With a Genetic Predisposition
While genetic predisposition is a major factor in the risk of developing age-related dementia, and Alzheimer’s disease in particular, environmental factors such as diet also have an important role to play. Thanks to the 12-year follow-up of nearly 2,800 French people over the age of 65, a research team has sought to understand the impact of meals high in sugars (simple sugars and refined carbohydrates) on the risk of developing dementia. Its research shows a link between the consumption of sugars during the afternoon snack and the risk of developing Alzheimer’s disease in people with genetic predispositions.
- Press releases - 15.06.2020
COVID-19: Vaccine Research at Inserm
Developing an effective and safe vaccine is one of the priority objectives in the fight to contain the COVID-19 pandemic. At Inserm, a dozen teams are involved in vaccine research projects. In particular, three initiatives have recently been selected by France’s Ministry of Higher Education, Research and Innovation on the advice of the COVID-19 Analysis, Research and Expertise Committee (CARE) and Inserm’s REACTing consortium, in order to receive special support and thus accelerate research.